论文部分内容阅读
我们应用米托蒽醌 (MIT)、足叶乙甙 (VP1 6 )、阿糖胞苷 (Ara- C) ,简称MEA方案治疗急性髓系白血病 (AML )4 4例 ,取得较好的疗效。现报告如下。1 资料与方法1.1 临床资料1997年 4月— 2 0 0 0年 8月住院的AML患者 4 4例。均经临床及骨髓细胞形态学、组织细胞化学染色和免疫
We used mitoxantrone (MIT), etoposide (VP1 6), cytarabine (Ara-C), referred to as MEA regimen in the treatment of acute myeloid leukemia (AML) 44 cases, and achieved good results. The report is as follows. 1 Materials and Methods 1.1 Clinical data April 1997 - August 2004 AML patients hospitalized 44 cases. Both clinical and bone marrow cell morphology, histochemical staining and immunization